HSR21-067: What Patient-Reported Outcomes Are Being Used in Non-small Cell Lung Cancer? A Targeted Literature Review of Randomized Clinical Trials and Regulatory Labeling

Authors:
Kajal Patel GlaxoSmithKine, Collegeville, PA

Search for other papers by Kajal Patel in
Current site
Google Scholar
PubMed Close
 PhD
,
Soham Shukla GlaxoSmithKine, Collegeville, PA

Search for other papers by Soham Shukla in
Current site
Google Scholar
PubMed Close
 PharmD
,
Jennifer Hanlon GlaxoSmithKline, Waltham, MA

Search for other papers by Jennifer Hanlon in
Current site
Google Scholar
PubMed Close
 MPH
,
Kelly Bell GlaxoSmithKine, Collegeville, PA

Search for other papers by Kelly Bell in
Current site
Google Scholar
PubMed Close
 PharmD
,
Laurie Eliason GlaxoSmithKline, Waltham, MA

Search for other papers by Laurie Eliason in
Current site
Google Scholar
PubMed Close
 MPH
, and
Cosmina Hogea GlaxoSmithKline, Philadelphia, PA

Search for other papers by Cosmina Hogea in
Current site
Google Scholar
PubMed Close
 PhD
Volume/Issue:
Volume 19: Issue 3.5
Online Publication Date:
17 Mar 2021
DOI:
https://doi.org/10.6004/jnccn.2020.7726
Restricted access

Corresponding Author: Kajal Patel, PhD
  • Collapse
  • Expand
Print ISSN:
1540-1405
Online ISSN:
1540-1413
Publisher:
National Comprehensive Cancer Network
Cover Journal of the National Comprehensive Cancer Network
Copyright:
Copyright © 2021 by the National Comprehensive Cancer Network 2021
Article Category:
Abstract
Print Publication Date:
20 Mar 2021
Online Publication Date:
17 Mar 2021

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 1464 538 112
PDF Downloads 538 0 0
EPUB Downloads 0 0 0